Skip to main content

Table 4 Criteria for successful completion

From: Lifestyle intervention in BRCA1/2 mutation carriers: study protocol for a prospective, randomized, controlled clinical feasibility trial (LIBRE-1 study)

Attendance of 70% of the planned lifestyle intervention events (training sessions and nutrition courses) within the first 3 months
• Conduct of study visit after 1 year
• No withdrawal of informed consent within 1 year
• No new occurrence of any of the exclusion criteria during the first 3 months